S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 8.02 CNY -0.5%
Market Cap: ¥5.3B

Relative Value

The Relative Value of one Shandong Sinobioway Biomedicine Co Ltd stock under the Base Case scenario is 2.07 CNY. Compared to the current market price of 8.02 CNY, Shandong Sinobioway Biomedicine Co Ltd is Overvalued by 74%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
2.07 CNY
Overvaluation 74%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Shandong Sinobioway Biomedicine Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
5.3B CNY 20.5 -24 -17.3 -17.3
ZA
Sasol Ltd
JSE:SOL
124.7B ZAR 0.5 51.8 5.3 5.3
DE
Basf Se
XETRA:BAS
42.8B EUR 0.7 26.4 8.7 22.8
CN
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
247.2B CNY 5.6 23 20.2 20.2
IN
Pidilite Industries Ltd
NSE:PIDILITIND
1.4T INR 9.7 59.8 40.9 46.3
ZA
Omnia Holdings Ltd
JSE:OMN
13.7B ZAR 0.6 11.5 7 7
JP
Resonac Holdings Corp
XMUN:SWD
10.5B EUR 1.4 66.4 17.1 51.7
JP
Showa Denko KK
TSE:4004
1.9T JPY 1.4 66.2 17.2 51.9
IN
SRF Ltd
NSE:SRF
742.2B INR 4.8 41.6 22.1 28.8
JP
Mitsubishi Chemical Holdings Corp
TSE:4188
1.2T JPY 0.3 13.6 5.5 18.1
JP
Mitsubishi Chemical Group Corp
F:M3C0
6.5B EUR 0.3 13.1 5.4 17.7
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett